meldepliktige handler fra primærinnsidere

← Alle transaksjoner

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA (VISTN) · publisert 2021-05-19 06:30 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplassTolket via
Hilde Merete Hagen VP Quality & Regulatory Affairsdisposal214 182 NOK2021-05-18NO0010734122Oslo Stock Exchange, MIC: XOSLrules

Vedlegg

Meldingstekst

Hilde Merete Hagen, VP Quality & regulatory Affairs in Vistin Pharma ASA, and a primary insider, has on 18th of May 2021 sold 14 182 shares in Vistin Pharma ASA at an average price of NOK 24.0 per share. Following this transaction Hilde Merete Hagen do not hold any shares in Vistin Pharma ASA.